LEXARIA BIOSCIENCE CORP. Cash Equivalents, at Carrying Value
LEXARIA BIOSCIENCE CORP. (LEXX) had Cash Equivalents, at Carrying Value of $5.80 million as of 2022-08-31, per its 10-K filed 2022-11-28.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashEquivalentsAtCarryingValue · last filed 2022-11-28
- 2022-08-31: Cash Equivalents, at Carrying Value $5.80M.
- 2021-11-30: Cash Equivalents, at Carrying Value $10.90M.
- 2021-08-31: Cash Equivalents, at Carrying Value $10.90M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2022-08-31 | $5.80M 10-K · filed 2022-11-28 |
| 2021-11-30 | $10.90M 10-Q · filed 2022-01-14 |
| 2021-08-31 | $10.90M 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |